Juan María Vázquez Morón

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study

María Chaparro, Iria Bastón‐Rey, E Fernández-Salgado et al. · Inflammatory Bowel Diseases · 2022 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

María Chaparro, Diana Acosta, Cristina Rodríguez et al. · The American Journal of Gastroenterology · 2022 · 32 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease

María Chaparro, Ana Garre, María Fernanda Guerra Veloz et al. · Journal of Crohn s and Colitis · 2019 · 31 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +10

Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal

Estefanía Moreno-Rincón, J M Benítez, Francisco Javier Serrano-Ruiz et al. · Inflammatory Bowel Diseases · 2015 · 28 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab

Juan María Vázquez Morón, Héctor Pallarés Manrique, Ignacio Javier Martín-Suárez et al. · Revista Española de Enfermedades Digestivas · 2013 · 26 citations · Full text

Life Sciences, Immunology, Internal Medicine +17